4//SEC Filing
SCHIERMEIER ANDREW 4
Accession 0001209191-21-001718
CIK 0001652130other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:58 PM ET
Size
14.7 KB
Accession
0001209191-21-001718
Insider Transaction Report
Form 4
SCHIERMEIER ANDREW
EVP, Dev and Corp Strategy
Transactions
- Sale
Common Stock
2021-01-05$55.86/sh−1,377$76,919→ 16,656 total - Exercise/Conversion
Common Stock
2020-12-31+4,792→ 18,033 total - Award
Stock Option (right to buy)
2020-12-31+9,583→ 9,583 totalExercise: $20.56From: 2020-12-31Exp: 2028-03-20→ Common Stock (9,583 underlying) - Award
Restricted Stock Unit (performance-based)
2020-12-31+4,792→ 4,792 totalFrom: 2020-12-31→ Common Stock (4,792 underlying) - Exercise/Conversion
Restricted Stock Unit (performance-based)
2020-12-31−4,792→ 0 totalFrom: 2020-12-31→ Common Stock (4,792 underlying)
Footnotes (4)
- [F1]Includes 568 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on December 31, 2020.
- [F2]Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of 4,792 performance-based restricted stock units ("PRSUs") on December 31, 2020.
- [F3]On May 1, 2018, the reporting person was granted an option to purchase 28,750 shares of common stock pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. The award had performance-based vesting, with one-third of the award vesting upon each achievement of three scientific and regulatory milestones through the calendar year 2020 (the "Performance Milestones"). On December 31, 2020, one of the Performance Milestones was achieved, resulting in the vesting of the option as to 9,583 shares.
- [F4]On May 1, 2018, the reporting person was granted 14,375 PRSUs pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. Each PRSU represents a contingent right to receive one share of the Company's common stock upon vesting, with one-third of the PRSUs vesting upon each achievement of the Performance Milestones through the calendar year 2020. On December 31, 2020, one of the Performance Milestones was achieved, resulting in the vesting of 4,792 PRSUs.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001738456
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 8:58 PM ET
- Size
- 14.7 KB